Pereira Brian JG

CIK 00012981466 companiesWINSTON SALEM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001298146

Recent Transactions

50 trades

Sale
PROKIDNEY CORP.$PROK
Class A Common Stock
2026-08-20$1.42/sh−222,948→ 0 total
Sale
PROKIDNEY CORP.$PROK
Class A Common Stock
2026-08-20$1.42/sh−27,052→ 0 total
Sale
PROKIDNEY CORP.$PROK
Class A Common Stock
2026-08-19$1.44/sh−222,949→ 222,948 total
Sale
PROKIDNEY CORP.$PROK
Class A Common Stock
2026-08-19$1.44/sh−27,051→ 27,052 total
Sale
PROKIDNEY CORP.$PROK
Class A Common Stock
2026-08-18$1.37/sh−27,826→ 54,103 total
Sale
PROKIDNEY CORP.$PROK
Class A Common Stock
2026-08-18$1.37/sh−229,338→ 445,897 total
Conversion
PROKIDNEY CORP.$PROK
Class A Common Stock
2026-08-04+675,235→ 675,235 total
Conversion
PROKIDNEY CORP.$PROK
Common Units in ProKidney Holdings, LLC
2026-08-04−81,929→ 0 total
Conversion
PROKIDNEY CORP.$PROK
Class A Common Stock
2026-08-04+81,929→ 81,929 total
Conversion
PROKIDNEY CORP.$PROK
Common Units in ProKidney Holdings, LLC
2026-08-04−675,235→ 0 total
Conversion
PROKIDNEY CORP.$PROK
Class B Common Stock
2026-08-04−81,929→ 0 total
Conversion
PROKIDNEY CORP.$PROK
Class B Common Stock
2026-08-04−675,235→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2026-06-11−30,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2026-06-11−10,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2026-06-11−7,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2026-06-11−10,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2026-06-11−14,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2026-06-11−10,000→ 0 total
Disposition to Issuer
KalVista Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2026-06-11−10,000→ 0 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2026-05-28+135,000→ 135,000 total
Sale
PROKIDNEY CORP.$PROK
Class A Common Stock
2025-11-13$2.37/sh−447,803→ 0 total
Sale
PROKIDNEY CORP.$PROK
Class A Common Stock
2025-11-13$2.37/sh−54,333→ 0 total
Sale
PROKIDNEY CORP.$PROK
Class A Common Stock
2025-11-12$2.72/sh−27,595→ 54,333 total
Sale
PROKIDNEY CORP.$PROK
Class A Common Stock
2025-11-12$2.72/sh−227,431→ 447,803 total
Award
KalVista Pharmaceuticals, Inc.
Stock Option (right to buy)
2025-10-01+30,000→ 30,000 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2025-05-29+125,862→ 125,862 total
Conversion
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2025-02-04+675,234→ 675,234 total
Conversion
PROKIDNEY CORP.$PROK
Common Units in ProKidney LP
2025-02-04−675,234→ 675,235 total
Conversion
PROKIDNEY CORP.$PROK
Class B Ordinary Shares
2025-02-04−81,928→ 81,929 total
Conversion
PROKIDNEY CORP.$PROK
Common Units in ProKidney LP
2025-02-04−81,928→ 81,929 total
Conversion
PROKIDNEY CORP.$PROK
Class A Ordinary Shares
2025-02-04+81,928→ 81,928 total
Conversion
PROKIDNEY CORP.$PROK
Class B Ordinary Shares
2025-02-04−675,234→ 675,235 total
Award
KalVista Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2024-10-03+10,000→ 10,000 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2024-05-30+62,558→ 62,558 total
Award
KalVista Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-09-26+10,000→ 10,000 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2023-06-29+48,128→ 48,128 total
Award
KalVista Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2022-10-13+10,000→ 10,000 total
Award
PROKIDNEY CORP.$PROK
Common Units in ProKidney LP
2022-07-11+1,514,326→ 1,514,326 total
Award
PROKIDNEY CORP.$PROK
Class B Ordinary Shares
2022-07-11+1,514,326→ 1,514,326 total
Award
KalVista Pharmaceuticals, Inc.
Director Stock Option (Right to Buy)
2021-09-30+10,000→ 10,000 total
Award
KalVista Pharmaceuticals, Inc.
Director Stock Option (right to buy)
2020-10-01+7,000→ 7,000 total
Award
ABEONA THERAPEUTICS INC.$ABEO
Employee Stock Option (right to buy)
2020-04-15+930,000→ 930,000 total
Award
KalVista Pharmaceuticals, Inc.
Director Stock Option (Right to Buy)
2019-02-01+14,000→ 14,000 total
Award
ALBIREO PHARMA, INC.
Stock Option (right to buy)
2014-03-04+10,000→ 10,000 total
Sale
ALBIREO PHARMA, INC.
Common Stock
2013-12-20$2.26/sh−4,734→ 0 total
Award
ALBIREO PHARMA, INC.
Stock Option (right to buy)
2013-03-05+5,000→ 5,000 total
Award
ALBIREO PHARMA, INC.
Stock Option (right to buy)
2012-03-08+20,000→ 20,000 total
Sale
ALBIREO PHARMA, INC.
Common Stock
2011-12-16$0.65/sh−15,000→ 18,937 total
Exercise/Conversion
ALBIREO PHARMA, INC.
Restricted Stock Units
2011-09-30−3,937→ 0 total
Exercise/Conversion
ALBIREO PHARMA, INC.
Common Stock
2011-09-30+3,937→ 3,937 total

Companies

Recent Filings

Address

C/O PROKIDNEY CORP 2000 FRONTIS PLAZA BLVD, SUITE 250

WINSTON SALEM, NC, 27103

View on SEC.gov